GeneNews' Q3 Revenues Dip on Lower Licensing Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews reported after the close of the market Monday that its third-quarter revenues dropped more than 50 percent on lower licensing revenue year over year.

The Toronto-based firm brought in total revenues of C$166,515 (US$163,309) for the three-month period ended Sept. 30, compared to C$362,964 for the third quarter of 2009. Its license revenue declined to C$162,619 from C$311,684 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.